How to Source Sarilumab for Pharmaceutical Formulation

Sarilumab (injection (prefilled syringe), 150 mg/1.14 mL, 200 mg/1.14 mL) is classified under Immune Disorder. It is therapeutically aligned with reference brands such as Kevzara (USA/EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Sarilumab for formulation, R&D, or bulk manufacturing.

Product Overview: Sarilumab is a fully human monoclonal antibody that targets the interleukin‑6 (IL‑6) receptor (both membrane‑bound and soluble forms). By blocking IL‑6 from binding to its receptor, sarilumab inhibits the IL-6 mediated inflammatory signaling pathway. This reduces inflammation, immune‑mediated damage, and other symptoms associated with autoimmune inflammatory diseases such as rheumatoid arthritis and polymyalgia rheumatica.

Sarilumab API in injection (prefilled syringe) form, 150 mg/1.14 mL, 200 mg/1.14 mL specification
Sarilumab API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Sarilumab must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Sarilumab is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Sarilumab is more than procurement—it’s a strategic partnership. With its injection (prefilled syringe) form and 150 mg/1.14 mL, 200 mg/1.14 mL specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Sarilumab.

Request a Quote

Frequently Asked Questions For Sourcing of Sarilumab

What is the typical lead time for Sarilumab?

Lead times range from 4–6 weeks depending on supplier and region.

Is Sarilumab available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Sarilumab require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Sarilumab?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Sarilumab?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Sarilumab?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Sarilumab suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Sarilumab be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.